Mitoxantrone-loaded superparamagnetic iron oxide nanoparticles as drug carriers for cancer therapy: Uptake and toxicity in primary human tubular epithelial cells

Entry of aminoglycosides into renal tubular epithelial cells via endocytosis-dependent and endocytosis-independent pathways

(2014) Junya Nagai et al.   BIOCHEMICAL PHARMACOLOGY

Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges

(2014) Sophie Laurent et al.   Expert Opinion on Drug Delivery

The current role of mitoxantrone in the treatment of multiple sclerosis

(2014) Eleonora Cocco et al.   Expert Review of Neurotherapeutics

Development of a lauric acid/albumin hybrid iron oxide nanoparticle system with improved biocompatibility

(2014) Jan Zaloga et al.   International Journal of Nanomedicine

Magnetic Drug Targeting Reduces the Chemotherapeutic Burden on Circulating Leukocytes

(2013) Christina Janko et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Efficient drug-delivery using magnetic nanoparticles — biodistribution and therapeutic effects in tumour bearing rabbits

(2013) Rainer Tietze et al.   Nanomedicine-Nanotechnology Biology and Medicine

A Physiologically Based Pharmacokinetic Model of Mitoxantrone in Mice and Scale-up to Humans: a Semi-Mechanistic Model Incorporating DNA and Protein Binding

(2012) Guohua An et al.   AAPS Journal

The Effect of Nanoparticle Size, Shape, and Surface Chemistry on Biological Systems

(2012) Alexandre Albanese et al.   Annual Review of Biomedical Engineering

A novel small-molecule screening strategy identifies mitoxantrone as a RhoGTPase inhibitor

(2012) Aurélien Bidaud-Meynard et al.   BIOCHEMICAL JOURNAL

Vectorial secretion of CTGF as a cell-type specific response to LPA and TGF-β in human tubular epithelial cells

(2012) Jonathan Zuehlke et al.   Cell Communication and Signaling

Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers

(2012) Wahajuddin et al.   International Journal of Nanomedicine

Distinct Mesenchymal Alterations in N-Cadherin and E-Cadherin Positive Primary Renal Epithelial Cells

(2012) Christof Keller et al.   PLoS One

Mitoxantrone Inhibits HIF-1  Expression in a Topoisomerase II-Independent Pathway

(2011) Y.-M. Toh et al.   CLINICAL CANCER RESEARCH

Relationship of DNA damage signaling to DNA replication following treatment with DNA topoisomerase inhibitors camptothecin/topotecan, mitoxantrone, or etoposide

(2011) Hong Zhao et al.   CYTOMETRY PART A

Stabilization and functionalization of iron oxide nanoparticles for biomedical applications

(2011) Esther Amstad et al.   Nanoscale

The Use of Nanoparticles as Contrast Media in Neuroimaging: A Statement on Toxicity

(2011) Jesse L. Winer et al.   World Neurosurgery

Mitoxantrone is expelled by the ABCG2 multidrug transporter directly from the plasma membrane

(2010) László Homolya et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES

New biomarkers probing depth of cell senescence assessed by laser scanning cytometry

(2010) Hong Zhao et al.   CYTOMETRY PART A

High Intracellular Iron Oxide Nanoparticle Concentrations Affect Cellular Cytoskeleton and Focal Adhesion Kinase-Mediated Signaling

(2010) Stefaan J. H. Soenen et al.   Small

Safety and Tolerability of Ultrasmall Superparamagnetic Iron Oxide Contrast Agent

(2009) Hamm Bernd et al.   INVESTIGATIVE RADIOLOGY

Molecular Mechanisms of Receptor-Mediated Endocytosis in the Renal Proximal Tubular Epithelium

(2009) Akihiko Saito et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY